Received Apr 26, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 273H3 | IM / LA |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 2 | Z002437 | IM / LA |
Minor recently transferred to facility. Immunizations verified and entered into database. Database recommended second dose of Hep A, third dose of HPV, Mening B. Administered vaccines as recommended/ordered. While documenting, noticed that minor received Hep A and HPV on 03/09/2026 not clearly indicated in previous documentation. Minor evaluated post administration. Vital signs stable. Minor with no complaints at time evaluation.
Headache and sore throat at time of vaccination.
Headaches/Migraines,
Ibuprofen 600 mg - PRN for headaches no more than 3x a week.
No Known Allergies.